Geoffrey Glass

Geoff Glass is interim CEO of Abzena and has been Chairman of the company since June of 2022. Geoff is also CEO of KINICITI and serves as the Chairman of the Board for both Avadel Pharmaceuticals and Ncardia.

He almost three decades of executive experience in pharmaceutical and biotechnology therapeutic and services organizations. Geoff’s previous positions include Operating Partner at LongueVue Capital and CEO of Sancilio Pharmaceuticals. Geoff helped lead the turnaround of Patheon in executive leadership positions that included Executive Vice President of Sales and Marketing and President. Prior to Patheon, Geoff was a Senior Vice President at Valeant Pharmaceuticals.

Geoff began his career in management consulting at EY where he held various leadership positions in their global Life Sciences practice.